Dual GIP/GLP-1 Receptor Agonist in Obese Women Before Frozen Embryo Transfer

计划入组 1,510 人 · 首次发布于 2026 年 9 月 10 日

Glucagon-like Peptide 1 (GLP-1) Receptor Agonist Therapy and Exercise Training in People With Obesity

计划入组 40 人 · 首次发布于 2025 年 7 月 29 日

Efficacy of Glucagon-like Peptide-1 Receptor Agonists According to Type 2 Diabetes Subtypes

计划入组 130 人 · 首次发布于 2023 年 11 月 7 日

ZP-GG-72

GLP-1/GIP/glucagon receptor agonist (obesity)

GLP-1/GCGR dual agonists (Merck)

Alturas Minerals Corp

United States

Arvinas Estrogen Receptor, Inc.

United States

NHI-1

United States

MetaVia's Novel Dual Receptor Agonist Shows Promising 6.3% Weight Loss in Phase 1 Obesity Trial

Altimmune's Pemvidutide Obesity Program Gains FDA Agreement on Phase 3 Design

Altimmune Achieves FDA Agreement on Phase 3 Program for Pemvidutide in Obesity Treatment